KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $129.5 billion.

  • Merck's Liabilities and Shareholders Equity rose 1022.19% to $129.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $479.3 billion, marking a year-over-year increase of 827.02%. This contributed to the annual value of $117.1 billion for FY2024, which is 977.83% up from last year.
  • According to the latest figures from Q3 2025, Merck's Liabilities and Shareholders Equity is $129.5 billion, which was up 1022.19% from $117.5 billion recorded in Q2 2025.
  • Over the past 5 years, Merck's Liabilities and Shareholders Equity peaked at $129.5 billion during Q3 2025, and registered a low of $90.7 billion during Q2 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $107.1 billion (2022), whereas its average is $108.0 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 1809.17% in 2022, then crashed by 245.2% in 2023.
  • Merck's Liabilities and Shareholders Equity (Quarter) stood at $105.7 billion in 2021, then increased by 3.28% to $109.2 billion in 2022, then fell by 2.28% to $106.7 billion in 2023, then rose by 9.78% to $117.1 billion in 2024, then increased by 10.62% to $129.5 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $129.5 billion for Q3 2025, versus $117.5 billion for Q2 2025 and $115.1 billion for Q1 2025.